BILLS-119hr890ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (6)
02:38 Feb 28
2025
JANUARY 31
35
later than 1 year
42 U.S.C. 262(l
EVENT (2)
the ‘‘Stopping Pharma’s
SESSION
H.
GPE (2)
the United States
the United States of America
LOC (1)
IH
ORG (18)
House of Representa-
Office
United
7
States
CONGRESS
SEC
Senate
the Committee on the Judiciary of the
the Federal Food
U.S.C.
House of Representatives
United
States Patent and Trademark Office
Intellectual Property
USPTO REVIEW
Committee
Commerce
THE HOUSE OF REPRESENTATIVES
PERSON (2)
kjohnson
RYAN
Topic Classifications
congressional legislation
98.0%
public health
50.6%
government oversight
38.0%
Extracted Keywords
patent
distinct
double
drug
examination
product
review
director
proceeding
director shall
issuance
cal
office
biological product
guidance
Forensic Analysis
PDF Metadata
- Creator
- U.S. Gov. Printing Office -- G.S.D.D.
- ModDate
- D:20250301041053Z
- Producer
- Acrobat Distiller 24.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20250228163009-05'00'
Sentiment
Polarity
Positive
0.102
Subjectivity
30%
Objective
No crisis correlations found for this document.
The ML pipeline may still be processing.